{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "ALNT",
  "name": "Allient Inc.",
  "url": "https://orbyd.app/dossiers/ALNT/",
  "json_url": "https://orbyd.app/dossiers/ALNT.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Record-orders inflection: Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M vs $236.6M a year earlier — the first clean order break after two flat revenue years. Narrative is ACCELERATING, but the entire re-rating landed in three sessions into a 52-week high of $112.81 (2026-08-07, RSI 75.5) and nothing tests it until the Q3 print.",
  "invalidation_trigger": "A weekly close below $96 erases the entire 2026-08-05 post-print reaction (shares first traded to $96.02 on the report) and round-trips the record-orders quarter; secondary, a Q3 2026 book-to-bill under 1.0x or backlog printing below $298.0M.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year is the calendar year: Q2 2026 is the June quarter, released 2026-08-05 with the call on 2026-08-06.",
    "Quarterly dividend $0.04/share, record date 2026-08-19, payable 2026-09-02 — raised from the $0.03 paid 2026-04-03.",
    "Some data feeds and historical earnings pages still index the company under its former name, Allied Motion Technologies (AMOT)."
  ],
  "body_markdown": "## Current Thesis\n\nThe Q2 2026 report on 2026-08-05 broke a pattern: orders of $201.3M, up 49% year on year and described by the company as a record, a 1.31x book-to-bill, and backlog of $298.0M against $236.6M at the same point in 2025. That is the narrative leg on offer — a motion-control and power-components supplier whose order book inflected while gross margin printed 34.9%, up 170 basis points. The price has already absorbed a large share of it: the last completed close, 2026-08-07, was $112.81, the 52-week high, with RSI(14) at 75.5 and a three-month return of 69.3%.\n\n## Bull Case\n\n- **Orders $201.3M in Q2 2026, +49% YoY; book-to-bill 1.31x** (Q2 2026 results release, 2026-08-05). Backlog closed at $298.0M versus $236.6M at Q2 2025 quarter end — a 26% increase on the year.\n- **Revenue $153.770M vs $145.685M consensus; adjusted EPS $0.80 vs $0.61 consensus** (2026-08-05). GAAP net income was $10.4M, or $0.61 per diluted share, up 85% YoY. Adjusted EBITDA $23.7M, 15.4% of revenue.\n- **Gross margin 34.9%, +170bp YoY**, which the company called a record, attributed in the release to higher volume, mix and internal efficiency programs. Operating margin 10.2%.\n- **Balance sheet supports optionality**: cash $42.1M, total debt $173.3M, leverage ratio 1.63x at 2026-08-05. On the Q2 2025 call management said it was actively monitoring acquisition opportunities after deleveraging.\n- **Sell-side estimates are chasing, not leading**: JP Morgan maintained Overweight and raised its target from $80 to $95 on 2026-07-13, then from $95 to $120 on 2026-08-07 — two raises 25 days apart, the second after the move.\n- The dividend was raised to $0.04 per share (record 2026-08-19) from the $0.03 paid 2026-04-03.\n\n## Bear Case\n\n- **Cash conversion went the wrong way.** Free cash flow was -$18.31M in Q2 2026 against +$22.38M in Q2 2025; the release attributes it to higher receivables and inventory. The order build is being financed through working capital, and the deleveraging story reverses if that persists.\n- **The base is depressed.** Two-year revenue is flat (StockStory, 2026-08-05); the +10% reported growth (+9% organic constant-currency) is measured off a trough, not a trend.\n- **One quarter is one quarter.** A single 1.31x book-to-bill establishes nothing about a multi-year cycle. The Q3 print tests conversion of the $298.0M backlog and whether bookings hold above 1.0x.\n- **Rare-earth dependency is disclosed and unresolved.** On the Q2 2025 call management said $3–4M of revenue was pulled forward because customers were worried about heavy rare earth constraints, and described design work to reduce that dependency.\n- **Restructuring is still in the numbers** — the Q2 2026 release flags realignment costs tied to the Dothan transition.\n- **The visible target ceiling is close to spot.** JP Morgan's $120 (2026-08-07) sits modestly above the same day's $112.81 close. Further upside depends on estimate revisions rather than the gap to published targets.\n\n## Setup & Price Structure\n\n**Life-cycle: ACCELERATING.** What dates it: the 2026-08-05 beat and record-orders line, the 2026-08-06 earnings call, and two JP Morgan target raises (2026-07-13 to $95; 2026-08-07 to $120). The 52-week high was set on the pipeline's own last completed close, 2026-08-07 at $112.81 — 0.0% below the high.\n\n**Structure.** Shares traded up 3.1% to $96.02 immediately after the 2026-08-05 report (StockStory) and closed at $112.81 on 2026-08-07. The larger part of the advance therefore landed after the headline, across the call and the target raise. There is no consolidation shelf above $100 yet. The only defined structure beneath price is the post-print reaction area around $96.\n\n**Crowding and positioning observables** (stated as observables, not as a verdict):\n- RSI(14) 75.5 and 0.0% distance from the 52-week high, 2026-08-07.\n- +69.3% over three months into that high, with no pullback of consequence since the print.\n- a small-cap listing absorbing a step-change in attention.\n- No earnings date inside the next 30 days to interrupt or confirm the flow.\n- Both JP Morgan raises followed price rather than preceding it (2026-07-13, 2026-08-07).\n- Free cash flow was negative in the quarter that produced the re-rating.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-19** — record date for the $0.04 per share quarterly dividend. A cash-flow and capital-allocation datapoint, raised from $0.03; it resolves nothing about backlog conversion.\n- **2026-09-02** — dividend payment date.\n- **No earnings, guidance update or regulatory event is scheduled between 2026-08-08 and 2026-09-07.** The window is empty of anything that tests the thesis.\n- **~2026-11-04 (est., unconfirmed)** — Q3 2026 print. This is the next event that resolves whether the 49% order jump was demand or pull-forward. Prior-quarter cadence: Q2 released 2026-08-05, call 2026-08-06.\n\n## What Would Change Our Mind\n\nThe whole re-rating was built in three sessions on one quarter's order number, and the calendar contains nothing that re-tests it before November. The structural break is therefore the post-print reaction area rather than any near-term fundamental release: **a weekly close below $96** erases the entire 2026-08-05 reaction — shares first traded up to $96.02 on the report — and returns price to the pre-print range, meaning the record-orders quarter has been round-tripped in full.\n\nSecondary conditions, each independently observable:\n- Q3 2026 book-to-bill below 1.0x, or backlog printing below the $298.0M reported for Q2 2026, would show the order surge was timing rather than run-rate.\n- A second consecutive quarter of negative free cash flow with the leverage ratio rising from 1.63x would say the growth is consuming more cash than it generates.\n- The 30-day window closing on 2026-09-07 with no new order, contract or capacity datapoint while price remains extended above its rising short-term averages would move the read from ACCELERATING toward SATURATED — attention decaying into an empty calendar.\n\n## Correlation Notes\n\n- Trades in the same complex as small-cap precision-motion and industrial-component names; the sensitivity is to industrial capex sentiment and small-cap risk appetite rather than to any single end market disclosed by the company.\n- Rare-earth and permanent-magnet supply headlines feed straight into this name given the $3–4M pull-forward management disclosed on the Q2 2025 call.\n- FX is a visible wedge: Q2 2026 revenue grew 10% as reported and 9% organically on a constant-currency basis, so dollar strength trims the reported line.\n- Defence and unmanned-systems newsflow maps onto the order narrative by association — on the Q2 2025 call management was asked directly about unmanned-vehicle exposure and said it was positioning for those opportunities, without quantifying revenue.\n- Aftermarket data continuity is imperfect: some feeds and historical earnings pages still index the company under its former name, Allied Motion Technologies.",
  "first_seen": "2026-08-07",
  "last_analyzed": "2026-08-09T08:10:07+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}